bioAffinity Technologies, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Three
bioAffinity Technologies, Inc. (BIAF) had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $58.33 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2026-08-07
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $58.33K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $58.33K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $58.33K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2026-06-30 | $58.33K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $58.33K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $58.33K 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |